The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort)

C. Droz , C. Dureau , D. Thomas (1) , N. Danchin (2) , J. Tricoire , J. Benichou , F. Paillard (3) , S. Hercberg (4) , I. Sibon (5) , F. Rouanet , S. Rambelomanana , H. Maizi , M.A. Bernard , P. Blin , N Moore (6, 7)

1 IGDR - Institut de Génétique et Développement de Rennes
2 PARCC - UMR-S U970 - Paris-Centre de Recherche Cardiovasculaire
3 Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes]
4 Epidémiologie Nutritionnelle
5 Groupe de travail de la Société française neuro-vasculaire
6 Department of Pharmacology
7 Laboratoire de Pharmacologie Expérimentale

Domains: Life Sciences [q-bio]

C. Droz, C. Dureau, D. Thomas, N. Danchin, J. Tricoire, et al.. The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort). Value in Health, 2014, 17 (7), pp.A476. ⟨10.1016/j.jval.2014.08.1366⟩. ⟨hal-01116508⟩